KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Short-Term Debt issuances: 2009-2020

Historic Short-Term Debt issuances for Cme Group (CME) over the last 1 years, with Jun 2020 value amounting to -$100.0 million.

  • Cme Group's Short-Term Debt issuances rose 55.12% to -$100.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was -$636.6 million, marking a year-over-year decrease of 294.98%. This contributed to the annual value of -$304.6 million for FY2020, which is 229.30% down from last year.
  • Cme Group's Short-Term Debt issuances amounted to -$100.0 million in Q2 2020, which was up 51.12% from -$204.6 million recorded in Q1 2020.
  • Over the past 5 years, Cme Group's Short-Term Debt issuances peaked at $462.3 million during Q1 2019, and registered a low of -$222.8 million during Q2 2019.
  • For the 3-year period, Cme Group's Short-Term Debt issuances averaged around -$1.5 million, with its median value being -$131.4 million (2019).
  • Over the last 5 years, Cme Group's Short-Term Debt issuances had its largest YoY gain of 55.12% in 2020, and its largest YoY loss of 144.26% in 2020.
  • Over the past 3 years, Cme Group's Short-Term Debt issuances (Quarterly) stood at $386.9 million in 2018, then plummeted by 133.96% to -$131.4 million in 2019, then surged by 55.12% to -$100.0 million in 2020.
  • Its Short-Term Debt issuances stands at -$100.0 million for Q2 2020, versus -$204.6 million for Q1 2020 and -$131.4 million for Q4 2019.